The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram

Abstract

BACKGROUND Citalopram is the most commonly prescribed antidepressant in Canada. Concerns have been raised about its cardiac safety, and a dose-dependent prolongation of the QT interval has been documented. Drug interactions involving concomitant use of other medications that prolong the QT interval or increase citalopram levels by interfering with its… (More)
DOI: 10.2147/DHPS.S91046

Topics

5 Figures and Tables